» Articles » PMID: 3627281

Muscarine Receptors on the Rat Phrenic Nerve, Evidence for Positive and Negative Muscarinic Feedback Mechanisms

Overview
Specialty Pharmacology
Date 1987 Jun 1
PMID 3627281
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Neuronal transmitter stores of the rat phrenic nerve were labelled by incubation with [3H]choline. Release of [3H]acetylcholine was elicited by electrical nerve stimulation (100 or 1,500 pulses, 5 or 25 Hz) or by high potassium (27 mmol/l) and the effects of the muscarine receptor agonist oxotremorine and the antagonist scopolamine were investigated. Neither oxotremorine nor scopolamine affected the basal tritium efflux. A low concentration of oxotremorine (10 nmol/l) enhanced and a high concentration of oxotremorine (1 mumol/l) reduced the electrically evoked [3H]acetylcholine release. Likewise, the high potassium-evoked [3H]acetylcholine release was reduced by a high concentration of oxotremorine. Both effects of oxotremorine, increase and decrease, were abolished by a pretreatment (30 min before the first stimulation period) with 0.1 mumol/l scopolamine. Scopolamine (0.1 mumol/l) alone, enhanced [3H]acetylcholine release evoked by 100 pulses (5 Hz) or by high potassium. Scopolamine, however, reduced [3H]acetylcholine release evoked by 1,500 pulses (5 Hz or 25 Hz). The concentration-response curves obtained for scopolamine under these latter stimulation conditions were flat-running and biphasic which might indicate the involvement of two opposite effects (increase and decrease) of scopolamine under the present stimulation conditions. Both effects of scopolamine were reduced in the presence of 10 mumol/l neostigmine.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Balanced modulation of neuromuscular synaptic transmission via M1 and M2 muscarinic receptors during inhibition of cholinesterases.

Lenina O, Petrov K Sci Rep. 2022; 12(1):1688.

PMID: 35105922 PMC: 8807813. DOI: 10.1038/s41598-022-05730-w.


Cholinesterases in Tripartite Neuromuscular Synapse.

Petrov K, Proskurina S, Krejci E Front Mol Neurosci. 2022; 14:811220.

PMID: 35002624 PMC: 8733319. DOI: 10.3389/fnmol.2021.811220.


Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes.

Petrov K, Nikolsky E, Masson P Front Pharmacol. 2018; 9:766.

PMID: 30050445 PMC: 6052098. DOI: 10.3389/fphar.2018.00766.


Schwann cells sense and control acetylcholine spillover at the neuromuscular junction by α7 nicotinic receptors and butyrylcholinesterase.

Petrov K, Girard E, Nikitashina A, Colasante C, Bernard V, Nurullin L J Neurosci. 2014; 34(36):11870-83.

PMID: 25186736 PMC: 6608466. DOI: 10.1523/JNEUROSCI.0329-14.2014.


Protein kinase C isoforms at the neuromuscular junction: localization and specific roles in neurotransmission and development.

Lanuza M, Santafe M, Garcia N, Besalduch N, Tomas M, Obis T J Anat. 2013; 224(1):61-73.

PMID: 24102585 PMC: 3867888. DOI: 10.1111/joa.12106.


References
1.
Ringdahl B . A comparison of the stimulant activities of oxotremorine analogues on the frog rectus abdominis and the guinea pig ileum. Eur J Pharmacol. 1984; 99(2-3):177-84. DOI: 10.1016/0014-2999(84)90239-5. View

2.
Davison J, Greenwood B, Read N . The effects of atropine and secoverine on gastric secretion and motility in the mouse isolated stomach. Br J Pharmacol. 1983; 79(2):525-9. PMC: 2044866. DOI: 10.1111/j.1476-5381.1983.tb11027.x. View

3.
Hedlund B, Arhem P, Lorentz M, Sydbom A . Non-muscarinic effects of scopolamine on N1E-115 neuroblastoma cells. Acta Physiol Scand. 1986; 127(1):127-32. DOI: 10.1111/j.1748-1716.1986.tb07884.x. View

4.
ABBS E, Joseph D . The effects of atropine and oxotremorine on acetylcholine release in rat phrenic nerve-diaphragm preparations. Br J Pharmacol. 1981; 73(2):481-3. PMC: 2071681. DOI: 10.1111/j.1476-5381.1981.tb10446.x. View

5.
Haggblad J, Eriksson H, Heilbronn E . Oxotremorine acts as a partial nicotinic agonist on cultured chick myotubes. Acta Pharmacol Toxicol (Copenh). 1985; 57(5):317-21. DOI: 10.1111/j.1600-0773.1985.tb00051.x. View